First person – Tuba Sural-Fehr

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Tuba Sural-Fehr is first author on ‘Inhibition of the IGF-1–PI3K–Akt–mTORC2 pathway i...

Full description

Bibliographic Details
Format: Article
Language:English
Published: The Company of Biologists 2019-05-01
Series:Disease Models & Mechanisms
Online Access:http://dmm.biologists.org/content/12/5/dmm040402
id doaj-9b27f09b6f134d9dac0a52caaf59b190
record_format Article
spelling doaj-9b27f09b6f134d9dac0a52caaf59b1902020-11-25T02:18:19ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112019-05-0112510.1242/dmm.040402040402First person – Tuba Sural-FehrFirst Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Tuba Sural-Fehr is first author on ‘Inhibition of the IGF-1–PI3K–Akt–mTORC2 pathway in lipid rafts increases neuronal vulnerability in a genetic lysosomal glycosphingolipidosis’, published in DMM. Tuba conducted the research described in this article while a Postdoctoral Fellow in Dr Ernesto Bongarzone's lab at University of Illinois-Chicago, Chicago, USA.http://dmm.biologists.org/content/12/5/dmm040402
collection DOAJ
language English
format Article
sources DOAJ
title First person – Tuba Sural-Fehr
spellingShingle First person – Tuba Sural-Fehr
Disease Models & Mechanisms
title_short First person – Tuba Sural-Fehr
title_full First person – Tuba Sural-Fehr
title_fullStr First person – Tuba Sural-Fehr
title_full_unstemmed First person – Tuba Sural-Fehr
title_sort first person – tuba sural-fehr
publisher The Company of Biologists
series Disease Models & Mechanisms
issn 1754-8403
1754-8411
publishDate 2019-05-01
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Tuba Sural-Fehr is first author on ‘Inhibition of the IGF-1–PI3K–Akt–mTORC2 pathway in lipid rafts increases neuronal vulnerability in a genetic lysosomal glycosphingolipidosis’, published in DMM. Tuba conducted the research described in this article while a Postdoctoral Fellow in Dr Ernesto Bongarzone's lab at University of Illinois-Chicago, Chicago, USA.
url http://dmm.biologists.org/content/12/5/dmm040402
_version_ 1724882944134217728